Recently studies have shown that MYH9 participates in cancer cell migration, invasion, and metastasis, and MYH9 expression was significantly correlated with the adenocarcinoma histology [106–108], suggesting that the activation of MYH9 (p-value < 4.4 × 10–2) caused by acetylation can promote cell migration in middle stage LADC and may potentially increase LADC invasion and metastasis. This evidence concerns the gene MYH9 and adenocarcinoma.